Seqirus eyes swift introduction of influenza vaccines into S. Korea

Date:

Global leading influenza vaccine maker Seqirus Ltd. said it will swiftly bring its various products into South Korea amid the yearslong pandemic.

Seqirus, part of Australia-based biotech firm CSL Ltd., is one of the largest influenza vaccine companies in the world with pipelines in the US, Britain, and Australia. The company provides influenza vaccines to over 20 countries.

Seqirus set up its local corporate body, Seqirus Korea Ltd., in 2017, Yonhap news agency reported.

“We will try our best to bring various Seqirus vaccines into the country as quickly as possible,” Seqirus Korea CEO Yoo Gee-seung said during an online press conference.

You also highlighted the importance of administering an influenza vaccine at the right time to boost its effectiveness after mid-October, especially as the Covid-19 pandemic continues.

Seqirus currently provides its influenza virus vaccine, Afluria Quadrivalent, in South Korea. The product can be used on adults, as well as children aged five or older.

The company said it plans to bring in two other influenza vaccines — Fluad Quadrivalent and Flucelvax Quadrivalent — sometime soon.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Popular

More like this
Related

OM Trailer Sparks Comparisons with Dhurandhar and Avatar Among Netizens

The much-awaited trailer of Dhanush’s upcoming film OM was...

Vishwak Sen’s Legacy Postponed to February 2027

Mass Ka Das Vishwak Sen’s upcoming film Legacy has...

Dulquer Salmaan’s Next Telugu Film Likely to Be a Romantic Comedy

Malayalam star Dulquer Salmaan is reportedly preparing for another...

Megastar Chiranjeevi’s Kaaka: Grand Promotional Campaign to Kick Off on December 1

Megastar Chiranjeevi’s upcoming film Kaaka is gearing up for...